Drugs for Perioperative Therapy of two phases of Solid Tumors

摘要

1. A drug for preoperative treatment of two-stage solid tumors was developed by using a preparation with tumor specific drugs and another preparation with anticancer activity and close relationship with the former preparation. This means that it is necessary to better determine the location of its anti-cancer activities, reduce the number of stages of use, and possibly reduce the dose of anti-cancer, thus reducing the lateral impact, but at the same time maintaining its effectiveness. D. Claim 2: Employment under claim 1Agents labeled as tumor specific contain one or more specific antibodies to tumor related antigens. 13. Claim 3: used according to claim 2, which is characterized in that the antibody or antibody in the drug is a biotoxin and is combined with an avidin compound, which is a biotoxin compound containing an anticancer agent. Claim 4 employment provided under claim 2,It is characterized in that the antibody in the drug is avidina, and is combined with a biological group compound containing an anticancer agent. Claim 6: any employment under claims 2 to 5, which is characterized by antibody resistance. 19. Claim 8: used in accordance with any of the above requirements, characterized by the fact that the anticancer agent is selected from a group consisting of radioisotopes, chemokinetic agents, toxins and anticancer cells. D. Claim 9: Employment in accordance with claim 8,It is characterized by the selection of this radioisomer from fe-52, mn-52m, co-55, Cu-64, Ga-67, Ga-68, Tc-99m, In-111, I-123, I-125, I-131, P-32, sc-47, cu-67, Y-90, pd-109, ag-111, I-131, pm-149, Re-186, Re-188, at-211, pb-212, bi-212, lu-177 and other groups. Claim 25: a two-stage concurrent system and / or local and near functional antiretroviral therapy package, comprising a separate set of containers, the first containing specific biological antigen antibodies related to tumors or antibody mixtures, The second container contains an avidin compound,The third package contains a biotoxin compound containing an anticancer agent, while the fourth package contains biological albumin.